FeesSafety
Pluang+

Chatham Lodging Trust shares jump 73% with strong Q2 and raised AFFO guidance

Analyst Insights
26 Aug 2026, 01:46 WIB
Seeking Alpha
View Source
Bullish
Chatham Lodging Trust shares jump 73% with strong Q2 and raised AFFO guidance

Chatham Lodging Trust (CLDT) has seen its share price rise 73% since March, outperforming other hotel REITs. The company raised its AFFO guidance to $1.28–$1.34 per share, driven by strong Q2 results, margin expansion, and record revenue per available room (RevPAR), especially in Silicon Valley properties. CLDT's valuation gap with peers has narrowed, now trading at 10.35x AFFO and 0.88x price-to-book, still undervalued but less so. The analyst maintains a 'Buy' rating, citing a strong balance sheet and potential further gains from Silicon Valley's recovery.

More News

Atos secures contract to manage and unify France's shared medical records platform with Mon Espace Santé.

Atos secures contract to manage and unify France's shared medical records platform with Mon Espace Santé.

Atos has been selected by France's Caisse nationale de l’Assurance Maladie (Cnam) to manage and secure the Dossier Médical Partagé (DMP) and integrate it with Mon Espace Santé (MES) into a unified digital health platform. This platform, serving over ...

Market News
Bullish
32 minutes ago
Atos completes integration of France's Shared Medical Record with Mon Espace Santé platform

Atos completes integration of France's Shared Medical Record with Mon Espace Santé platform

Atos has successfully transitioned and integrated France's Shared Medical Record (DMP) with the Mon Espace Santé (MES) platform, creating a unified, secure digital health infrastructure for over 60 million insured people. This integration supports th...

Market News
Bullish
32 minutes ago
Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics raises $60M seed round to advance novel immune therapy for cancer and autoimmune diseases

Commit Biologics secured $60 million in seed funding led by Ackermans & van Haaren with participation from AbbVie Ventures, M Ventures, and others. The funds will support clinical development of COM002, a first-in-class immune engager targeting cance...

Company Fundamentals
Bullish
3 hours ago
Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes targets double-digit revenue and EPS growth by 2029 with AI-driven industrial solutions.

Dassault Systèmes announced at its 2026 Capital Markets Day a new growth cycle aiming for double-digit revenue and EPS growth by 2029, targeting over €8 billion in revenue and €1.80 in non-IFRS diluted EPS. The company highlights its transition to su...

Market News
Bullish
3 hours ago
Dassault Systèmes targets double-digit revenue and EPS growth by 2029, driven by AI and subscription model.

Dassault Systèmes targets double-digit revenue and EPS growth by 2029, driven by AI and subscription model.

Dassault Systèmes announced a new growth cycle aiming for double-digit increases in revenue and diluted EPS by 2029, with revenue expected to exceed €8 billion and EPS €1.80. This growth is supported by a strong subscription model, accelerating adopt...

Company Fundamentals
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App